Originally published by our sister publication Infectious Disease Special Edition
By Gina Shaw
The U.S. Preventive Services Task Force (USPSTF) issued updated recommendations for HIV prophylaxis classifying all three currently available pre-exposure prophylaxis (PrEP) medications as grade A recommendations.
The previous recommendations, issued in 2019, gave a grade A recommendation to the daily oral agent tenofovir disoproxil fumarate with emtricitabine (Truvada, Gilead). The new